Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations

By Park In   Kim Jin   Jung Jae   Han Ji-Youn  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 791-799

Springer Publishing Company

Access to resources Recommend Favorite

Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor

By Yeboah D.   Sun M.   Kingdom J.   Baczyk D.   Lye S.J.   Matthews S.G.   Gibb W.  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 12, 2006-12 ,pp. : 1251-1258

NRC Research Press

Access to resources Recommend Favorite

Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

By  

Current Drug Metabolism, Vol. 11, Iss. 7, 2010-09 ,pp. : 603-617

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro and in Vivo Metabolism of the Anti-Cancer Agent CI-1040, a MEK Inhibitor, in Rat, Monkey, and Human

By Wabnitz Paul A.   Mitchell David   Wabnitz David A.M.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1670-1679

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced gene expression of renin–angiotensin system, TGF-β₁, endothelin-1 and nitric oxide synthase in right-ventricular hypertrophy

By Park H.K.   Park S.J.   Kim C.S.   Paek Y.W.   Lee J.U.   Lee W.J.  

Pharmacological Research, Vol. 43, Iss. 3, 2001-03 ,pp. : 265-273

Academic Press

Access to resources Recommend Favorite